Try my Google Co-op search engine to search authoritative health and geriatric/gerontology sites on the WWW

Monday, October 29, 2007

Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease (2) 2007 addendum.

Following the outcome of a judicial review in August 2007, NICE has amended and reissued this guidance. The amended guidance clarifies the steps healthcare professional should take when assessing whether Alzheimer's disease is of moderate severity and highlights that clinicians should be mindful of the need to secure equality of access to treatment

http://www.nice.org.uk/guidance/TA111/guidance/pdf/English

No comments: